Even when AI scribes save time, note quality and proper coding (HCCs) vary wildly - there's no standardized way to measure if AI notes are actually good
Scans AI-generated notes against clinical guidelines, coding requirements, and payer rules to score quality, flag errors, and identify revenue leakage from miscoded encounters
SaaS per-encounter pricing ($0.50-2 per note) or monthly subscription
The JAMA study you referenced is a watershed moment — it proved AI scribe quality is inconsistent. Compliance officers are terrified of audit risk from AI-generated notes. Revenue cycle teams know miscoded HCCs = millions in leaked revenue. Quality teams have no standardized way to measure AI note quality across vendors. The pain is real, urgent, and tied to both regulatory risk and direct revenue impact. Docking 1 point because many health systems are still in early AI scribe adoption and haven't yet felt this pain acutely.
TAM estimate: ~1M US physicians generating ~3B ambulatory encounters/year. If 30% are AI-scribed within 3 years = ~900M encounters. At $0.50-2/encounter, that's a $450M-1.8B TAM. Realistic SAM in years 1-3 is $50-150M targeting large health systems and quality-conscious groups. Not a massive TAM compared to the scribe market itself, but solid for a SaaS startup. The per-encounter model scales naturally with AI scribe adoption.
Health systems already pay $3-8/chart for retrospective coding review (Apixio, Reveleer). $0.50-2/note for prospective quality scoring is cheap by comparison, especially if you can demonstrate even 1-2% revenue uplift from coding optimization. Compliance risk alone justifies the spend — a single OIG audit finding on AI-generated notes could cost millions. The buyer (quality/compliance/rev cycle) has budget authority. Docking points because health system procurement is slow and new budget line items face resistance.
A solo dev can build a functional MVP in 4-8 weeks that ingests notes and runs rule-based quality checks against coding guidelines. BUT: the hard part is clinical accuracy — you need validated clinical logic, up-to-date HCC coding rules (ICD-10-CM/HCC mapping changes annually), and payer-specific rule sets. LLMs can help but hallucination risk in clinical contexts is a liability. You'll need clinical advisor input and likely HIPAA-compliant infrastructure from day one. Not impossible but more complex than typical SaaS.
This is the strongest signal. NO existing product specifically scores AI-generated clinical notes as an independent third party. Existing CDI tools audit human notes. AI scribe vendors grade their own work. There is a genuine white-space opportunity for an independent AI note quality auditor. The 'fox guarding the henhouse' problem with scribe vendors self-reporting quality is a powerful positioning angle.
Textbook recurring revenue. Every encounter generates a note that needs scoring. Volume grows as AI scribe adoption increases. Health systems won't turn off quality monitoring once implemented — it becomes part of compliance infrastructure. Per-encounter pricing naturally scales with usage. Switching costs increase as historical quality trend data accumulates.
- +Clear white-space: no independent third-party AI note quality scorer exists today
- +Picks-and-shovels play — grows automatically as AI scribe adoption accelerates
- +Multiple buyer personas with budget: quality teams, compliance, revenue cycle
- +Direct ROI story: coding optimization pays for the tool many times over
- +Regulatory tailwinds: CMS/OIG scrutiny of AI-generated documentation is increasing
- +Per-encounter pricing model is familiar to healthcare buyers and scales naturally
- !AI scribe vendors (Nuance, Abridge, Fathom) could build quality scoring into their own platforms, reducing need for third-party tool
- !Health system procurement cycles are 6-18 months — long time to first enterprise deal
- !Clinical validation is table stakes: one false quality flag in a clinical context destroys credibility
- !HIPAA compliance, SOC 2, and potentially HITRUST certification required before enterprise sales — adds time and cost
- !EHR integration complexity (Epic, Cerner, etc.) could be a bottleneck for data ingestion
AI-powered ambient clinical documentation that generates notes from patient-physician conversations, with built-in quality metrics and coding suggestions
AI-driven clinical documentation integrity and CDI
Leading AI ambient scribe companies that include some internal quality checks and note accuracy metrics within their platforms
AI-powered risk adjustment and retrospective chart review platforms that analyze clinical documentation for HCC coding accuracy and revenue optimization
Start with a web app that accepts uploaded/pasted AI-generated clinical notes (no EHR integration yet). Score notes against three dimensions: (1) HCC coding completeness — flag missed diagnoses that should have been coded, (2) documentation compliance — check for required elements per CMS E/M guidelines, (3) clinical consistency — flag contradictions within the note. Output a quality scorecard with specific improvement suggestions. Target 3-5 beta health systems willing to manually export notes for review. Focus on one specialty (primary care or internal medicine) where HCC coding matters most.
Free pilot (50 notes) to demonstrate ROI -> Per-encounter pricing ($0.50-1/note) for individual practices -> Monthly subscription ($2K-10K/month) for health system departments -> Enterprise platform license ($100K-500K/year) with EHR integration, dashboards, and benchmarking -> Expand to payer-side (health plans auditing their delegated provider AI notes) for $1M+ contracts
8-14 weeks to MVP with manual note upload. 3-5 months to first paying pilot customer (likely a forward-thinking medical group or small health system). 6-9 months to first meaningful recurring revenue ($5-10K MRR). 12-18 months to enterprise contracts if clinical validation data is compelling.
- “There's still the question of the quality and standardisation of the notes”
- “tangential benefits like proper coding (hccs)”
- “AI scribes are a spectrum and some work better than others”
- “If they can show improvement there then there's at least a reason”